LOBBYIST

Katherine Cotton

207ACTIVITIES

11ORGS REPRESENTED

6BILLS

Revolving door — covered positions

Federal positions Katherine held before / during the 2-year LDA window. This is the credibility signal — who they were inside the building before they started lobbying it.

Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie

Organizations represented

Orgs whose LD-2 filings list Katherine as an active lobbyist, sorted by activity volume.

Todd Strategy Group96 activities American Medical Association28 activities Pharmaceutical Research and Manufacturers of America (PhRMA)22 activities Bristol Myers Squibb12 activities Eli Lilly and Company12 activities National Education Association9 activities U.s. Chamber of Commerce Global Innovation Policy Center9 activities NCTA - The Internet & Television Association6 activities American Society of Nephrology5 activities Coalition for the 21St Century5 activities U.S. Chamber of Commerce3 activities

Bills they file on

S. 86415 mentions

H.R. 13839 mentions

H.R. 16728 mentions

H.R. 9468 mentions

H.R. 52694 mentions

H.R. 14064 mentions

Topics in Filings

Policy topics Katherine files on across all their LD-2 activities.

Medicare and Medicaid Issues×22

HELP Copays Act×15

Physician Payment Reform×14

Intellectual property protection×12

Prescription Drug Pricing Policy×12

Part D changes×11

Prescription drug payment reform. 340B issues×11

General Medicare and Medicaid Issues×11

Drug Pricing and Access×11

Pharmaceutical Supply Chain×11

Pharmacy Benefit Managers×11

Show all 69 topics (+57 more) ▾

Medicare/Medicaid payment reform×10

Supply Chain Issues×10

Alzheimer's Disease×10

General higher education issues×9

Secure Rural Schools Reauthorization×9

Medicare Contractor Reform×9

Maintaining Investments in New Innovation Act×8

ORPHAN Cures Act×8

General telecommunications issues×6

Biosimilars reimbursement issues×6

Pharmacy Benefit Manager Reform×6

Anti Obesity Medication×6

Medicare/Medicaid Coverage and Reimbursement×6

PDUFA. 340B Program×6

Kidney transplantation policy×5

Medicare coverage and reimbursement for diagnostics×5

FDA LDT Regulation×5

Prior Authorization for Medicare Advantage×5

Prescription drug pricing, including MDRP×4

Substance Use Disorder Policy×4

Medicaid drug rebate program×4

Medicare Physician Fee Schedule Provider Reimbursement×4

PAMA AUC×4

Value of imaging×4

General Education on Apollo Global Management×4

Insurance regulation×4

Prescription drug pricing×4

Prostate cancer screening×4

Women's health×4

340B Program×4

Home Infusion for Part B Products×4

Medicare Reimbursement for New Technologies×4

Pediatric Priority Review Voucher Program×4

General issues×4

Diagnostics for patients with rare disease×4

Multi-Cancer Early Detection×4

Drug pricing×4

Medicare reimbursement for diagnostics×4

Lab test regulatory and reimbursement reform×4

Medicare Reimbursement for Prescription Drugs×4

Screening and Diagnosis×4

PET scan coverage and reimbursement and dementia care. 340B Program×4

PPRV×4

General education on kidney care×4

General education about Calyxo×4

Medicare coverage of molecular testing for solid organ allograft rejection×4

Medicare payment of clinical laboratory tests×4

Prior authorization of molecular tests×4

General education on Compass Pharmaceuticals×4

Mental health and PTSD×4

Labor-HHS Appropriations Bill×4

General education on the School Reform×4

Education around innovative testing for early detection of lung cancer and draft×4

Lung Cancer Screening and Prevention Act×4

Oncology/Artificial Intelligence×4

Hepatitis C Funding×4

March-in rights×1

Issue mix

LDA general-issue codes weighted by activity count.

Health Issues75

Medicare/Medicaid70

Pharmacy15

Education9

Taxation/Internal Revenue Code8

Telecommunications6

Economics/Economic Development4

Financial Institutions/Investments/Securities4

Budget/Appropriations4